Polyphenolics From Red Grape Seeds May Treat Alzheimer's Disease
Mount Sinai researchers have discovered that polyphenolics derived from red grape seeds may be useful agents to prevent or treat Alzheimer's Disease(AD). This new study explored the possibility of developing 'wine mimetic pills' that would replace the recommended beneficial glass of red wine a day for AD prevention. Giulio Maria Pasinetti, senior author and Director of the NCCAM-NIH funded Center of Excellence for Research in Complementary and Alternative Medicine in Alzheimer's Disease at Mount Sinai School of Medicine and his collaborator Dr. Jun Wang of Mount Sinai, through a partnership between the Research Center at Mount Sinai School of Medicine and Dr. Anil Shrikhande, the Director of the Polyphenolics Division of Constellation Brands, a producer of biologically active grape products, tested the hypothesis that certain molecules contained in red wine, in particular in red grape seeds currently being developed with the name of Meganatural AZ, might offset disease progression in mice genetically modified to develop Alzheimer' disease. read more
Read the whole article on Scientific Blogging
More from Scientific Blogging
Related
- Potential new role for red grape seeds in treatment of Alzheimer's diseaseTue, 17 Jun 2008, 17:42:59 EDT
- Mount Sinai researchers discover novel mechanisms that might causally link type-2 diabetes to Alzheimer's diseaseFri, 10 Apr 2009, 11:42:41 EDT
- Mount Sinai researchers find new Alzheimer's disease treatment promisingSun, 12 Jul 2009, 7:28:36 EDT
- Study shows how to boost value of Alzheimer's-fighting compoundsMon, 17 Aug 2009, 14:43:20 EDT
- Mounting evidence shows health benefits of grape polyphenolsWed, 29 Oct 2008, 11:16:43 EDT